Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
Date:2/18/2009

, $25.3 million for the year ended December 31, 2008 and $18.3 million for the year ended December 31, 2007. Management estimates stock compensation expense of $32.0 million to $35.0 million in 2009, approximately $35.0 million to $40.0 million in 2010 and approximately $35.0 million to $40.0 million in 2011. The reconciliation of this measure to the estimated GAAP net income is as follows (in millions):



                              Year       Year
                             Ended      Ended
                 Q4    Q4   December   December    2009      2010       2011
                2008  2007  31, 2008   31, 2007  Guidance  Guidance   Guidance

    GAAP net
     income                                     $(15.0) -    $35.0 -   $60.0 -
     (loss)     $24.5  $2.6  $30.8    $(15.8)    $0           $40.0     $65.0
    Non-cash
     stock
     compensation                                 32.0 -      35.0 -    35.0 -
     expense      7.4   5.5   25.3      18.3       35.0        40.0      40.0
    Non-GAAP                                     $17.0 -     $70.0 -   $95.0 -
     net income $31.9  $8.1  $56.1      $2.5      $35.0       $80.0     $105.0


Management believes that this non-GAAP information is useful to investors, taken in conjunction with BioMarin's GAAP information because Management uses such information internally for its operating, budgeting and financial planning purposes, and to enhance investors' overall understanding of the company's prospects for the future.

Diluted Earnings Per Share Calculation

GAAP diluted earnings per share for the fourth quarter of 2008 and non-GAAP diluted earnings per share for the fourth quarter and full year 2008 includes 26.3 million shares related to the outstanding convertible debt. The calculation of GAAP diluted earnings per share for the fourth quarter of 2008 and non-GAAP diluted earnings per share for the fourth quarter
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
2. BioMarin to Present at the Piper Jaffray Healthcare Conference
3. BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
4. BioMarin to Present at the Credit Suisse Healthcare Conference
5. BioMarin Announces Third Quarter 2008 Financial Results
6. BioMarin Corrects Information Included in Bloomberg Article
7. BioMarin to Present at the Merrill Lynch Global Pharmaceutical Conference
8. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
9. BioMarin to Present at the Citi Biotech Day
10. BioMarin Announces Roll-Out of National PKU Registry
11. BioMarin to Host Second Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, August 5 at 5:00 p.m. ET (23:00 CET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... The Kidney Cancer Association (KCA) has established a CNN iReport ... News. , Bill Bro, KCA CEO, says, “We’re pleased ... international news organization. When we began using iReport last month, ... program highlights news of an enzyme that is lost in ... Kidney Cancer News also presents a report on outcomes from ...
(Date:7/30/2014)... July 30, 2014 W. R. ... release of the REVELERIS® Prep purification system ... preparative chromatographers, and other researchers to perform both ... single unit. , With the REVELERIS® Prep purification ... preparative chromatography modes with a simple touch of ...
(Date:7/30/2014)... While administrative claims and other data ... a relatively long period of time, there has ... of these ‘big data’ for comparisons of interventions ... powerful computer technology with the plethora of data ... significant promise for identifying optimal interventions for specific ...
(Date:7/30/2014)... 30, 2014 July 30, 2014. ... biotechnology firm that provides DNA-based authentication and security solutions ... Vice President of Life Sciences, a newly created position, ... Dr. Hogan will lead APDN’s drive to build its ... biotech and healthcare customers, provide guidance to APDN’s R&D ...
Breaking Biology Technology:Grace Launches New REVELERIS® Prep Purification System 2Leveraging ‘Big Data’ - Methodological Considerations in Health Services Research, New Webinar Hosted by Xtalks 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3
... 25 f-star, an antibody,engineering company developing ... unique Modular Antibody Technology, today announced the,appointment ... Officer. Dr. Mudde has,over 20 years of ... in preclinical research and development. He comes ...
... Genetics Professionals Should Be Part of Genetic Testing Process Says ... American College of ... tests are,available than ever before, ranging from home DNA test ... diseases, and even home,paternity tests. Along with greater availability of ...
... Sept. 25 /PRNewswire/-- News briefs concerning the,economic and ... the Tampa Bay,Partnership: Tampa Bay Diamond Manufacturer ... Corporation recently broke ground for a planned,expansion of ... other locations, the firm decided to remain in ...
Cached Biology Technology:Antibody Engineering Company f-Star Appoints Geert Mudde as Chief Scientific Officer 2Statement on Direct-To-Consumer Genetic Testing 2Statement on Direct-To-Consumer Genetic Testing 3Highlights of Economic and Business Growth in the Tampa Bay Region 2Highlights of Economic and Business Growth in the Tampa Bay Region 3Highlights of Economic and Business Growth in the Tampa Bay Region 4
(Date:7/30/2014)... increase in Impact Factors for its molecular bioscience ... (Thomson Reuters, 2014) show that Clinical Science ... Biochemistry , Biochemical Society Transactions and ... their Impact Factors. The journals are owned by ... Limited. , 2014 Impact Factors (2013 Impact Factor ...
(Date:7/30/2014)... Brembs, professor of neurogenetics at the Institute of Zoology, ... readers and reviewers to run the underlying code within ... forward for scientific publishing, by demonstrating a completely novel ... , Figure 3 in fact doesn,t really exist. The ... F1000Research , and the figure is generated ,on the ...
(Date:7/30/2014)... use of iodine-125 (125I) in cancer treatment has ... root ganglia are critical for neural transmission between ... Zhang and colleagues from Institute of Radiation Medicine, ... 125I could be implanted into rat dorsal root ... 125I seeds with different radioactivity (0, 14.8, 29.6 ...
Breaking Biology News(10 mins):Across-the-board Impact Factor increases for Portland Press Limited 2F1000Research brings static research figures to life 2
... are resourceful survivors with plenty of tricks for staying alive. ... lacking the tumor suppressor BRCA1 can resume one form of ... appears in the January 21 st issue of ... The BRCA1 protein helps to mend double-strand DNA breaks by ...
... to climate change could cause soils to release additional ... but that effect diminishes over the long term, finds ... Change . The study, from University of New Hampshire ... California-Davis and the Marine Biological Laboratory, sheds new light ...
... the childhood cancer neuroblastoma reinforces the challenges in ... Contrary to expectations, the scientists found relatively few ... for neuroblastoma treatment. Instead, say the researchers, they ... in response to medicine and other factors. ...
Cached Biology News:Enzyme helps cancer cells avoid genetic instability 2Enzyme helps cancer cells avoid genetic instability 3Warmer soils release additional CO2 into atmosphere; Effect stabilizes over longer term 2Warmer soils release additional CO2 into atmosphere; Effect stabilizes over longer term 3Tumors evolve rapidly in a childhood cancer, leaving fewer obvious tumor targets 2
NAP-2 (5C7)...
... (rapid amplification of cDNA ends) technique that ... and 3' cDNA ends. The GeneRacer Kit ... (RT) for improved amplification of the full-length ... The RNase H portion of SuperScript II ...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
... Bean Nuclease catalyzes the degradation of single-stranded ... terminated products. While the nuclease prefers ssDNA ... concentrations the enzyme degrades double-stranded DNA from ... been used for transcript mapping studies (3,4), ...
Biology Products: